Skip to main content
    N

    Neogen Corporation (NEOG)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $10.88
    -0.35 (-3.12%)

    Market Cap: $2.45B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Neogen Corporation (NEOG) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Neogen (NEOG) to earn $0.33 per share in the fiscal year ending May 31, 2027, on revenue of $888.08M. Of 4 analysts, 3 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending May 31, 2027 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 75% of the ratings.

    RatingAnalystsShare
    Strong Buy250.0%
    Buy125.0%
    Hold125.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    4

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 36.4% and revenue estimates fall 6.8%.

    Fiscal year ending May 31, 2027
    $0.33
    EPS consensus, revenue $888.08M
    Fiscal year ending May 31, 2028
    $0.45
    EPS consensus, revenue $827.73M
    Next report
    Jan 6, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    May 31, 2027$0.33$0.31 to $0.363$888.08M$886.60M to $889.22M4
    May 31, 2028$0.45$0.39 to $0.512$827.73M$827.00M to $828.20M3

    Quarterly Estimates

    Across the 3 quarters below, the EPS consensus is lowest for the quarter ending May 31, 2027, at -$0.01, and highest for the quarter ending Feb 28, 2027, at $0.08.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Nov 30, 2026$0.06$0.06 to $0.073$223.05M$222.20M to $223.40M4
    Feb 28, 2027$0.08$0.07 to $0.103$214.32M$213.10M to $215.10M4
    May 31, 2027-$0.01-$0.03 to $0.016$232.44M$222.66M to $239.82M6

    Estimate Revisions

    Across the 4 periods below, the last 30 days brought 5 upward and 4 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending May 31, 202730
    Fiscal year ending May 31, 202801
    Quarter ending Nov 30, 202603
    Quarter ending Feb 28, 202720

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending May 31, 2027 has risen 10.0% from $0.30.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending May 31, 2027$0.33$0.31$0.31$0.31$0.30+11.1%
    Fiscal year ending May 31, 2028$0.45$0.43$0.43$0.43$0.42+7.1%
    Quarter ending Nov 30, 2026$0.06$0.08$0.09$0.09$0.10-34.5%
    Quarter ending Feb 28, 2027$0.08$0.07$0.07$0.07$0.07+24.9%

    Frequently Asked Questions About NEOG

    What is the NEOG stock forecast?

    Consensus analyst estimates put Neogen's EPS at $0.33 for the fiscal year ending May 31, 2027, on revenue of $888.08M. The consensus rating from 4 analysts is Buy.

    How do analysts rate NEOG stock?

    Of 4 analysts covering Neogen, 2 rate it Strong Buy, 1 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from NEOG next year?

    For the fiscal year ending May 31, 2027, the consensus EPS estimate is $0.33, with estimates from $0.31 to $0.36 from 3 analysts. For the fiscal year ending May 31, 2028, the consensus EPS estimate is $0.45, with estimates from $0.39 to $0.51 from 2 analysts.

    What revenue do analysts expect from Neogen next year?

    For the fiscal year ending May 31, 2027, the consensus revenue estimate is $888.08M, with estimates from $886.60M to $889.22M. For the fiscal year ending May 31, 2028, the consensus revenue estimate is $827.73M, with estimates from $827.00M to $828.20M.

    How many analysts cover NEOG?

    4 analysts rate Neogen stock, and 3 analysts estimate its EPS for the fiscal year ending May 31, 2027.